RPRX Stock Ownership Activity

ROYALTY PHARMA PLC- CL A 13F holders

1 value investing guru has made changes to the ROYALTY PHARMA PLC- CL A (RPRX) position according to the gurus' latest SEC quarterly report(s). The number of RPRX shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying RPRX now?

According to the latest SEC filing(s) ROYALTY PHARMA PLC- CL A (RPRX) has been bought by Robert Torray - Torray Fund (added shares +33.28%).

To see more about who is investing in ROYALTY PHARMA PLC- CL A (RPRX), please go to the RPRX ownership page.

2024 Q3 (1 result)
Robert Torray
+33.28%
+126,275
+1.03%
4.13%
Current price: $26.07 10.20% Reported price*: $29.03
2024 Q1 (1 result)
Robert Torray
+40.10%
+108,615
+0.96%
3.34%
Current price: $26.07 14.07% Reported price*: $30.34
2023 Q2 (1 result)
Robert Torray
buy
+270,835
+2.65%
2.65%
Current price: $26.07 15.19% Reported price*: $30.74
3 of 3

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.